Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/3318
Title: INSILICO AND PHARMACOLOGICAL PROPERTY ANALYSIS OF BIOACTIVE COMPONENTS FROM PRUNUS AVIUM AGAINST DIABETICS
Authors: Veerapandi L
Nivetha T
Sinthiya R
Karunyah Amirthadharshini N
Bumaasri K
Aishwarya R
Issue Date: 1-Jan-2022
Publisher: Informatics Publishing Limited & Natural Remedies Pvt.Ltd
Abstract: Diabetes is a common metabolic disorder, which effects people across all cultures globally. Lifelong distress is the cause of this disease which has no cure as of now. Various medications available in the market are too expensive and not easily affordable by all. Rural people rely on plant based Ayurvedic medications to heal diabetes as these contain anti-diabetic compounds. These phytoconstituents/anthocyanin derivatives work with several mechanisms that involve phytoconstituent interactions and target molecules in diabetic metabolism. Molecular docking analysis aids in finding out the interaction between receptors and ligands to identify the finest interaction which suits the target. In this case, the study proposed examining the bonding interactions of anti-diabetic compounds/anthocyanin derivatives derived from medicinal plants (Pelargonidin, Cyanidin, Delphinidin, Peonidin, Petunidin, Quercetin and pancreatic alpha-amylase (4X9Y)) with the help of the computational tool. ADME/T test helps decide different pharmacological and physicochemical analysis of lead atoms, degree of adsorption inside the cell, digestion rate, solvency, blood cerebrum boundary penetrability, cancer-causing nature and so on, which are the significant essentials prior to advertising a medication. Peonidin and Quercetin was proposing the best interactions. Nonetheless, to discover a better cure for diabetes, further in-vitro/ in vivo studies have to be carried out.
URI: https://www.informaticsjournals.com/index.php/jnr/article/view/27660/20891
Appears in Collections:National Journals



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.